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DNA damage regulates direct association of TOR 
kinase with the RNA polymerase II–transcribed 
HMO1 gene
ABSTRACT The mechanistic target of rapamycin complex 1 (mTORC1) senses nutrient suffi-
ciency and cellular stress. When mTORC1 is inhibited, protein synthesis is reduced in an 
intricate process that includes a concerted down-regulation of genes encoding rRNA and 
ribosomal proteins. The Saccharomyces cerevisiae high-mobility group protein Hmo1p has 
been implicated in coordinating this response to mTORC1 inhibition. We show here that 
Tor1p binds directly to the HMO1 gene (but not to genes that are not linked to ribosome 
biogenesis) and that the presence of Tor1p is associated with activation of gene activity. Per-
sistent induction of DNA double-strand breaks or mTORC1 inhibition by rapamycin results in 
reduced levels of HMO1 mRNA, but only in the presence of Tor1p. This down-regulation is 
accompanied by eviction of Ifh1p and recruitment of Crf1p, followed by concerted dissocia-
tion of Hmo1p and Tor1p. These findings uncover a novel role for TOR kinase in control of 
gene activity by direct association with an RNA polymerase II–transcribed gene.
INTRODUCTION
Mechanistic target of rapamycin (TOR) kinase is an evolutionarily 
conserved serine/threonine protein kinase that may be incorporated 
into two functionally distinct complexes, mTORC1 and mTORC2 
(Loewith and Hall, 2011). In Saccharomyces cerevisiae, mTORC1 
contains either Tor1p or Tor2p in complex with Kog1, Lst8, and 
Tco89, and the complex is sensitive to rapamycin, which inhibits 
mTORC1 activity and mimics responses to nutrient limitation (Loewith 
et al., 2002; Wedaman et al., 2003). In contrast, mTORC2 contains 
Tor2p and is generally insensitive to rapamycin (Wullschleger et al., 
2005). mTORC1 appears to be constitutively localized to the vacu-
ole, which is a significant nutrient reservoir, rationalizing this cellular 
localization (Sturgill et al., 2008; Binda et al., 2009). While mTORC1 
is active under nutrient sufficiency and promotes growth by phos-
phorylating downstream targets and controlling their cellular local-
ization, nutrient starvation and rapamycin treatment results in a sig-
nificant reduction in protein synthesis, in part by blocking initiation of 
translation (Barbet et al., 1996; Hardwick et al., 1999; Shamji et al., 
2000; Huber et al., 2009). In addition, decreased mTORC1 activity is 
also associated with various stress conditions, including DNA dam-
age (Reiling and Sabatini, 2006; Urban et al., 2007; Workman et al., 
2014; Desantis et al., 2015). The cell cycle arrest that accompanies 
unrepaired DNA damage must be coordinated with metabolic ar-
rest, and this process requires mTORC1 (Shen et al., 2007; Budanov 
and Karin, 2008; Dulic, 2013).
Two of the downstream targets of mTORC1, the AGC kinase 
Sch9p and the transcription factor Sfp1p have been implicated in 
activating expression of ribosomal protein (RP) genes and genes 
whose products are involved in ribosomal biogenesis (Ribi genes); 
together, these genes may account for ∼50% of transcriptional initia-
tion by RNA polymerase (Pol) II (Rudra and Warner, 2004; Martin 
et al., 2006). In contrast, regulation of some Pol I– and Pol III–tran-
scribed genes may be direct; Tor1p has been shown to bind to the 
yeast RNA Pol I– and III–transcribed 35S and 5S rRNA genes to 
activate transcription, whereas nutrient limitation and rapamycin 
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the HMO1 gene repression that occurs on inhibition of mTORC1 is 
similar to that proposed for RP genes.
We show here that Tor1p binds directly to the HMO1 gene to 
activate expression, particularly in the absence of Hmo1p. Persistent 
induction of DNA double-strand breaks (DSBs) or inhibition of 
mTORC1 by rapamycin results in a Tor1p-dependent reduction in 
HMO1 mRNA levels that is accompanied by fast displacement of 
Ifh1p and subsequent recruitment of Crf1p, followed by eviction of 
Hmo1p and Tor1p from the region surrounding the HMO1 transcrip-
tional start. Our data suggest that Tor1p controls gene activity by 
direct association with the HMO1 gene, indicating that direct regu-
lation of gene activity by promoter-bound TOR kinase includes RNA 
Pol II–transcribed genes.
RESULTS
Tor1p activates HMO1 expression
Using reporter constructs in which the lacZ gene encoding β-
galactosidase is under control of the HMO1 promoter, we previously 
reported that absence of Hmo1p results in increased promoter activ-
ity, whereas overexpression of Hmo1p leads to repression by com-
parison to wild-type cells (Xiao et al., 2011). Considering that Hmo1p 
is implicated in coordinating responses to mTORC1 inhibition by ra-
pamycin on rRNA, RP, and HMO1 genes, we created a tor1Δ strain 
and measured HMO1 promoter activity (Figure 1B). As previously 
reported, increased promoter activity was observed on deletion of 
HMO1 (∼2.4-fold), indicating that Hmo1p represses its own expres-
sion (Figure 1B). In a tor1Δ background, deletion of HMO1 likewise 
resulted in increased promoter activity (∼2.2-fold increase in pro-
moter activity in the hmo1Δtor1Δ strain compared with tor1Δ). Dele-
tion of TOR1 reduced gene activity, particularly in cells deleted for 
HMO1. Measurement of HMO1 transcript levels in wild-type (WT) 
and tor1Δ cells confirmed the modestly reduced HMO1 expression in 
tor1Δ cells (∼20%; Figure 1D). This suggests that Tor1p directly or in-
directly functions to activate the HMO1 promoter, particularly in the 
absence of Hmo1p. The data also suggest that Hmo1p-mediated 
repression of the HMO1 promoter activity occurs regardless of Tor1p.
If HMO1 promoter activity were controlled by mTORC1 activity, 
and because both Tor1p and Tor2p may be components of 
mTORC1, the inability of Tor2p to compensate for loss of Tor1p was 
somewhat unexpected. A cognate site for 
Fhl1p was previously identified ∼605 base 
pairs upstream of the HMO1 start codon 
(IFHL; Figure 1A); Fhl1p was shown to bind 
preferentially to this genomic location, and 
its binding was shown to depend on Hmo1p 
(Xiao et al., 2011). Mutation of this site 
resulted in failure to activate the HMO1 pro-
moter in the absence of Hmo1p, and dele-
tion of TOR1 did not reduce gene activity 
(Figure 1C). Taken together, these data sug-
gest that Tor1p-mediated activation of the 
HMO1 promoter requires the IFHL site and 
that Hmo1p represses activation by factor(s) 
that also require the IFHL site.
Tor1p binds the HMO1 gene and is 
required for reduced expression after 
persistent DSB
Persistent DNA damage is associated with 
an mTORC1-dependent reduction in meta-
bolic activity. Hmo1p is also linked to 
the DNA damage response because it is 
nucleus (Li et al., 2006; Wei et al., 2009). On the RNA Pol III–tran-
scribed 5S rDNA (ribosomal DNA encoding rRNA), chromatin-bound 
mTORC1 is responsible for regulating phosphorylation of the nega-
tive regulator Maf1 (Wei et al., 2009). Direct regulation of transcrip-
tion by TOR kinase is conserved in mammals, where mTOR was 
shown to interact with the Pol III transcription factor TFIIIC (Kantidakis 
et al., 2010; Tsang et al., 2010).
The yeast high-mobility group protein Hmo1p has been impli-
cated in communicating mTORC1 signaling to downstream target 
genes (Hall et al., 2006; Xiao and Grove, 2009; Panday and Grove, 
2017). It binds RP gene promoters and rDNA, and its presence is 
required for efficient down-regulation of gene activity when 
mTORC1 is inhibited (Gadal et al., 2002; Hall et al., 2006; Berger 
et al., 2007). On many RP gene promoters, Hmo1p assembles the 
transcription factors Forkhead-like 1 (Fhl1p) and Interacts with Fhl1p 
(Ifh1p) (Hall et al., 2006). A DNA sequence motif found in genes to 
which Fhl1p and Ifh1p bind, the IFHL motif is required for maximal 
RP gene transcription (Wade et al., 2004). Hmo1p and Fhl1p mutu-
ally promote binding of the other protein; it has been proposed that 
Fhl1p remains associated and recruits Ifh1p to promote transcrip-
tion, whereas inhibition of mTORC1 results in nuclear import of 
phosphorylated Corepressor with Fhl1p (Crf1p), which displaces 
Ifh1p, resulting in repression of gene activity (Jorgensen et al., 2004; 
Martin et al., 2004; Schawalder et al., 2004; Wade et al., 2004; Rudra 
et al., 2005; Zhao et al., 2006). Because Hmo1p promotes binding 
of Fhl1p, its absence results in an attenuated response to rapamy-
cin. Repression of RP gene expression was also reported to result in 
dissociation of Hmo1p and a concomitant ∼20–base pair upstream 
shift of the +1 nucleosome that buries the transcription start site 
within the nucleosome (Knight et al., 2014; Reja et al., 2015).
Hmo1p also localizes to its own promoter, and it negatively 
regulates its own expression. HMO1 promoter activity is likely 
stimulated by Fhl1p, as evidenced by reduced expression in 
hmo1Δ cells upon mutation of the IFHL site, which is located ∼605 
base pairs upstream of the translational start (Figure 1A) (Xiao 
et al., 2011). Consistent with this inference, HMO1 promoter activ-
ity is reduced in the presence of rapamycin, and this response is 
attenuated in hmo1Δ. Because Fhl1p binds the HMO1 promoter, 
centered on the IFHL site, it is conceivable that the mechanism of 
FIGURE 1: Activity of the HMO1 promoter depends on Tor1p and the IFHL site. (A) Region 
upstream of HMO1 ORF (black). The IFHL site (red) is centered ∼605 base pairs upstream of the 
HMO1 start codon and followed by three predicted Reb1p binding sites. Positions of amplicons 
used in ChIP shown below. (B) Activity of HMO1 promoter using lacZ reporter constructs. 
(C) Activity of HMO1 promoter using lacZ reporter constructs in which IFHL site is mutated. 
Activity is reported in Miller units. (D) HMO1 expression in WT and tor1Δ cells. The mRNA levels 
are reported relative to IPP1 and calculated using the ΔCt method. Data represent mean and SD 
from three independent experiments.
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(Figure 2C), perhaps reflecting slow protein 
turnover. Notably, HMO1 mRNA levels 
were not significantly affected in tor1Δ cells 
after persistent DSB, and this resulted in a 
modest accumulation of Hmo1p (Figure 2, 
D and F). These differences were not due 
to different efficiencies of DSB induction as 
a result of inactivating TOR1; as shown in 
Figure 3, the levels of DSB induction in WT 
and tor1Δ cells were not significantly differ-
ent. We previously reported that inhibition 
of mTORC1 with rapamycin resulted in re-
duced HMO1 promoter activity and that 
this response to rapamycin requires Hmo1p 
(Xiao et al., 2011). Consistent with this ob-
servation, addition of rapamycin resulted in 
decreased HMO1 expression (Figure 4A), 
and deletion of TOR1 significantly attenu-
ated the response to rapamycin (Figure 
4B). This indicates that the reduction in 
HMO1 mRNA levels observed following 
DSB induction or inhibition of mTORC1 by 
rapamycin requires Tor1p.
Considering the specific requirement for 
Tor1p for HMO1 gene regulation and previ-
ous reports that Tor1p associates with Pol 
I– and Pol III–transcribed genes, we used 
chromatin immunoprecipitation (ChIP) to in-
vestigate binding of FLAG-tagged Tor1p to 
the HMO1 gene. Notably, Tor1p was found 
throughout the promoter region (from ∼2 kb 
upstream of the translational start; positions 
Up1–Up3; Figure 1A) as well as within the coding region (ORF; 
Figure 5, B and C). Hmo1p, which was previously shown to bind its 
own promoter (Hall et al., 2006; Xiao et al., 2011), was also detected 
at all monitored loci (Figure 5A). By comparison, we observed the 
expected Tor1p accumulation at 35S rDNA (where Hmo1p also 
binds), whereas Tor1p was undetectable at MAT and at the POL5 
and KRE5 promoters (sites to which Hmo1p binds at different levels) 
and at the IPP1 gene promoter (a site to which Hmo1p binding was 
reported to be below background levels) (Hall et al., 2006; Panday 
et al., 2015; Figure 5C). This suggests that Tor1p binding to the 
HMO1 gene is specific and that binding does not correlate with 
Hmo1p occupancy. Notably, introduction of a DSB at the MAT locus 
FIGURE 2: Reduced HMO1 expression after DSB induction requires Tor1p. (A, D) HMO1 
expression in WT and tor1Δ cells before (Ctrl; gray bar) and after induction of HO endonuclease 
expression by addition of galactose (orange bars); HO endonuclease creates a DSB at the MAT 
locus. DNA repair is induced by addition of glucose (gray bars). Expression levels are normalized to 
that of control cells. Three independent experiments were performed. Error bars represent SD. 
(B, E) Representative gel images illustrating expression of HMO1 and IPP1 (reference gene) in WT 
and tor1Δ cells, respectively. (C, F) Western blot corresponding to expression data shown directly 
above using antibody to the FLAG tags. GAPDH or actin expression levels were used as internal 
loading controls, and the blots are representative of three independent experiments.
FIGURE 3: Efficiency of DSB induction. WT (solid line) and tor1Δ cells 
(dashed line) were collected before and after induction of HO 
expression by addition of galactose. Primers spanning the break site 
were used for amplification. Relative CT values are reported (using 
primers amplifying a fragment of POL5 as reference). An increase in 
relative CT value reflects reduced amount of template (a greater extent 
of DSB formation). Error bars represent SD from three measurements.
FIGURE 4: Reduced HMO1 expression after inhibition of mTORC1 
activity by rapamycin requires Tor1p. (A, B) HMO1 expression in 
wild-type (WT) and tor1Δ cells before (Ctrl; gray bars) and after 
addition of rapamycin (olive bars). Three independent experiments 
were performed. Error bars represent SD.
evicted along with core histones in preparation for DSB repair, and 
its absence generates a chromatin environment in which repair is 
faster (Panday et al., 2015, 2017; Panday and Grove, 2016, 2017). 
A DSB was produced at the mating-type locus MAT, a locus to 
which Hmo1p associates (Panday et al., 2015), by addition of ga-
lactose to induce expression of homothallic switching (HO) endo-
nuclease. As a result, HMO1 mRNA levels were significantly re-
duced and only slowly recovered upon DNA repair (addition of 
glucose; Figure 2, A and B). This reduction in gene activity was 
associated with only a modest decrease in cellular protein content 
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Tor1p dissociated from the HMO1 gene af-
ter prolonged exposure to rapamycin 
(Figure 8). The dissociation of Tor1p is con-
sistent with reports that it exits the nucleus 
after nutrient deprivation or rapamycin 
treatment (Li et al., 2006).
Repression of HMO1 is associated with 
differential binding of Ifh1p and Crf1p
While HMO1 mRNA levels were signifi-
cantly reduced after 30 min of DSB induc-
tion (Figure 2, A and B), eviction of Hmo1p 
and Tor1p was not observed until 2 h after 
addition of galactose to induce expression 
of HO endonuclease, when gene activity 
was minimal (Figures 6 and 7). Fhl1p binds 
the IFHL site located ∼605 base pairs up-
stream of the HMO1 start codon (Xiao 
et al., 2011). We therefore investigated 
whether regulation of HMO1 expression 
might depend on the Fhl1p-associated fac-
tors Ifh1p and Crf1p, focusing on primer 
pairs Up2 and Up1 that amplify segments 
that flank the IFHL site (Figure 1A). While 
Fhl1p remained bound after 2 h of DSB 
induction (Figure 9A), induction of a DSB 
for 30 min resulted in significantly reduced 
Ifh1p binding and a concomitant increase in 
binding of Crf1p (Figure 9, B and C). Simi-
larly, inhibition of mTORC1 by rapamycin 
resulted in reduced Ifh1p binding and in-
creased occupancy of Crf1p, whereas Fhl1p binding was unaltered 
(Figure 10). Consistent with previous reports that Hmo1p and Fhl1p 
binding is interdependent and that repression of HMO1 promoter 
activity by rapamycin is attenuated in the absence of Hmo1p (Xiao 
et al., 2011), little binding of Fhl1p or Ifh1p 
was detected in an hmo1Δ strain (unpub-
lished data).
The increase in binding of corepressor 
Crf1p and the loss of the activator Ifh1p ob-
served after 30 min of DSB induction and 
after 1 h of rapamycin treatment (Figures 9 
and 10) correlates with reduced HMO1 
mRNA levels (Figures 2 and 4) and with 
reduced HMO1 promoter activity upon 
addition of rapamycin (determined by β-
galactosidase activity of constructs in which 
the lacZ gene is under control of the HMO1 
promoter; Xiao et al., 2011). An interpreta-
tion consistent with these data and the re-
ported roles of Crf1p and Ifh1p in control-
ling RP gene expression is that recruitment 
of RNA Pol II is compromised as a conse-
quence of changing dynamics of Crf1p and 
Ifh1p binding. To address this inference 
experimentally, we performed a kinetic 
analysis of RNA Pol II binding by compari-
son with the kinetics of Crf1p and Ifh1p 
binding. On RPL30, a marked reduction in 
mRNA levels was seen 15 min after inhibi-
tion of mTORC1 with rapamycin with es-
sentially undetectable mRNA levels after 
FIGURE 5: Hmo1p and Tor1p bind the HMO1 gene. Quantification by qRT-PCR of ChIP using 
antibody to FLAG-tagged Hmo1p (A) or Tor1p (B). Data were normalized to corresponding 
input control. Primer pairs amplify segments upstream of the HMO1 ORF (Up3–Up1, blue 
bars; Figure 1A) or within the ORF (green bars). Three independent experiments were 
performed. Error bars represent SD. (C) ChIP showing Tor1p binding to indicated loci. IC, 
input control; No, no antibody; IP, immunoprecipitation with anti-FLAG antibody. Hmo1p was 
previously shown to bind 35S rDNA, MAT, and POL5 at a very low level to KRE5, and not to 
IPP1 (Hall et al., 2006; Panday et al., 2015; Panday and Grove, 2016). (D) Control for specificity 
of anti-FLAG antibody; ChIP using WT cells expressing no FLAG-tagged proteins and cells 
expressing FLAG-tagged Hmo1p. Primer pairs amplifying fragments Up1 (left) and ORF (right) 
are shown.
FIGURE 6: Hmo1p is evicted from the HMO1 gene after persistent DSB induction. Quantification 
by qRT-PCR of ChIP using antibody to FLAG-tagged Hmo1p after addition of galactose to induce 
DSB. Data were normalized to corresponding input control for each time point. Sites upstream of 
the HMO1 ORF (Up3–Up1, blue bars) or within the ORF (green bars) were monitored. Three 
independent experiments were performed. Error bars represent SD.
resulted in eviction of Hmo1p, but only after 2 h of DSB induction 
(Figure 6). Tor1p was also evicted after 2 h, but most efficiently in the 
vicinity of the HMO1 start site (Up1) and within the coding region 
(open reading frame [ORF]; Figure 7). Similarly, both Hmo1p and 
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galactose, as expected (Figure 11B, top 
row), but it was almost undetectable 10 min 
after DSB induction. Thus the dynamics of 
transcription factor binding is consistent 
with a failure to recruit RNA Pol II effectively 
if Ifh1p is absent; in addition, our data show 
that Crf1p recruitment occurs after dissocia-
tion of RNA Pol II, perhaps to maintain the 
repressed state. Similarly, addition of ra-
pamycin led to rapid disappearance of RNA 
Pol II from the HMO1 promoter, and Pol II 
was detectable only with primers amplify-
ing a fragment of the ORF after 10 min 
(Figure 11C).
Cell cycle progression is also affected 
by the activity of mTORC1. To verify that 
changes in transcription factor binding 
were not a consequence of a cell cycle ar-
rest, we used flow cytometry to assess cell 
cycle progression after addition of either 
galactose or rapamycin to asynchronous 
cells. As shown in Figure 12, no apparent 
change was observed 10 min after addi-
tion of galactose to induce DSB, the time 
at which both Ifh1p and RNA Pol II have 
left the HMO1 gene. After 2 h of DSB in-
duction, the time at which both Hmo1p 
and Tor1p were seen to dissociate, an accumulation of cells in G1 
was observed. We infer that binding of Ifh1p, Crf1p, and RNA Pol 
II is unrelated to cell cycle progression, whereas it is conceivable 
that dissociation of Hmo1p and Tor1p is a consequence of a G1 
delay.
Arrest in G1 has been reported to occur after >6 h of incubation 
with rapamycin, primarily due to impaired protein synthesis, and a 
G2/M defect was reported to occur on inhibition of mTORC1 by 
rapamycin due to mTORC1-mediated regulation of polo-like ki-
nase Cdc5 (Fingar and Blenis, 2004; Bernstein et al., 2007; 
Nakashima et al., 2008). We also noted a delay of G2/M progres-
sion after addition of rapamycin; however, a similar delay was 
90 min, whereas levels of Ifh1p were reduced to ∼20% of initial 
levels only 5 min after addition of rapamycin (Crf1p binding was 
not reported in this study; Schawalder et al., 2004). We therefore 
monitored binding at early time points after either HO induction or 
rapamycin addition.
Using primers that amplify a fragment near the IFHL site (Up1), 
Ifh1p was readily detected before addition of galactose to induce 
DSB, whereas Crf1p was not (Figure 11A). After 5 min, Ifh1p was 
barely detectable, consistent with its rapid dissociation from RPL30 
after addition of rapamycin. Binding of Crf1p occurred after a delay, 
and it was clearly detectable 15 min after DSB induction. By com-
parison, RNA Pol II localized to the HMO1 gene before addition of 
FIGURE 7: Tor1p is evicted from the HMO1 gene after persistent DSB induction. Quantification 
by qRT-PCR of ChIP using antibody to FLAG-tagged Tor1p after addition of galactose to induce 
DSB. Data were normalized to corresponding input control for each time point. Sites upstream 
of the HMO1 ORF (Up3–Up1, blue bars) or within the ORF (green bars) were monitored. Three 
independent experiments were performed. Error bars represent SD.
FIGURE 8: Binding of Hmo1p and Tor1p to the HMO1 gene is reduced after inhibition of mTORC1 by addition of 
rapamycin. Quantification by qRT-PCR of ChIP using antibody to FLAG-tagged Hmo1p (A) or Tor1p (B) after addition of 
rapamycin. Data were normalized to corresponding input control for each time point. Sites upstream of the HMO1 ORF 
(Up3–Up1, blue bars) or within the ORF (green bars) were monitored. Three independent experiments were performed. 
Error bars represent SD.
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observed in tor1Δ cells, consistent with the expectation that Tor2p 
can substitute for Tor1p as a component of mTORC1 (Figure 13). 
In addition, these data indicate that changes in HMO1 mRNA lev-
els on deletion of TOR1 are not due to changes in cell cycle pro-
gression compared with WT cells.
Excess Hmo1p displaces Reb1p but not Tor1p
The HMO1 promoter also features binding sites for the transcrip-
tional regulator Reb1p (Figure 1A), which often binds near nu-
cleosome-depleted regions (Hartley and Madhani, 2009). No 
change in Reb1p occupancy was observed after 30 min of DSB 
induction (Figure 14A), suggesting that Reb1p is not involved in 
mediating the initial decrease in gene expression. However, pro-
longed DSB induction (2 h) resulted in reduced Reb1p binding; 
the timing of reduced Reb1p binding corresponds to dissociation 
of Hmo1p and Tor1p (Figures 6 and 7). On the basis of the poten-
tial contribution of Reb1p to transcriptional activation, we moni-
tored binding of Reb1p in cells in which HMO1 is expressed un-
der control of the strong GAL1 promoter. Overexpression of 
Hmo1p resulted in modestly reduced Reb1p binding (Figure 
14B), suggesting that displacement of Reb1p by excess Hmo1p 
may contribute to the reduced HMO1 promoter activity observed 
FIGURE 9: Differential association of transcription factors Ifh1 and 
Crf1 with the HMO1 gene promoter after DSB induction. 
Quantification by qRT-PCR of ChIP using antibody to FLAG-tagged 
Fhl1p (A), Ifh1p (B), or Crf1p (C) after induction of DSB by addition of 
galactose. Data were normalized to corresponding input control for 
each time point. Sites flanking the IFHL site (Up2, blue; Up1, dark 
blue) were monitored. Three independent experiments were 
performed. Error bars represent SD.
FIGURE 10: Differential association of transcription factors Ifh1 and 
Crf1 with the HMO1 gene promoter after inhibition of mTORC1 by 
addition of rapamycin. Quantification by qRT-PCR of ChIP using 
antibody to FLAG-tagged Fhl1p (A), Ifh1p (B), or Crf1p (C) after 
addition of rapamycin. Data were normalized to corresponding input 
control for each time point. Sites flanking the IFHL site (Up2, blue; 
Up1, dark blue) were monitored. Three independent experiments 
were performed. Error bars represent SD.
FIGURE 11: Dynamics of Ifh1p, Crf1p, and RNA Pol II binding to the 
HMO1 gene. (A) ChIP using antibody to FLAG-tagged Ifh1p or Crf1p 
before (0 min) and after addition of galactose to induce DSB. Primers 
amplifying fragment Up1 were used. IC, input control; No, no 
antibody; IP, immunoprecipitation with anti-FLAG antibody. (B) ChIP 
using antibody to RNA Pol II before (0 min) and after addition of 
galactose. (C) ChIP using antibody to RNA Pol II before (0 min) and 
after addition of rapamycin. Primer pairs amplifying fragments 
upstream of the HMO1 ORF (Up1–Up3) or the ORF are identified 
between B and C. IC, input control; No, no antibody; IP, 
immunoprecipitation with anti–Pol II antibody. Data are representative 
of duplicate experiments.
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DISCUSSION
Tor1p associates with the HMO1 gene 
to activate transcription
mTORC1 controls transcription by all three 
nuclear RNA polymerases. In yeast, mTORC1 
associates to a significant extent with the lim-
iting membrane of the vacuole (the primary 
nutrient reservoir in yeast and the equivalent 
of lysosomes in higher eukaryotes), where it 
phosphorylates one of the main downstream 
targets, Sch9p, during nutrient sufficiency 
to activate downstream functions (Urban 
et al., 2007; Jin et al., 2014). Inactivation of 
mTORC1 has been linked to reduced ex-
pression of RP genes by a mechanism in 
which mTORC1 promotes phosphorylation 
of Crf1p by the cytoplasmic serine/threonine 
protein kinase Yak1p, which leads to localiza-
tion of phosphorylated Crf1p to the nucleus, 
where it replaces Ifh1p. In addition, direct 
phosphorylation of the transcription factor 
Sfp1p by mTORC1 promotes its nuclear lo-
calization and binding to RP gene promoters, 
whereas rapamycin treatment results in 
Sfp1p dephosphorylation and its export from 
the nucleus (Jorgensen et al., 2004; Marion 
et al., 2004; Lempiäinen et al., 2009).
By contrast, TOR kinase from both yeast 
and mammals has been shown to associate 
directly with the RNA Pol I– and Pol III–transcribed rRNA genes in a 
nutrient-dependent manner, perhaps functioning to phosphorylate 
specific transcription factors or components of the transcription ma-
chinery. Our data suggest that TOR kinases likewise have a direct 
role in control of RNA Pol II–transcribed 
genes. Tor1p associates directly with the 
HMO1 gene (Figure 5, B and C), and it acti-
vates transcription, provided the IFHL site is 
present (Figure 1, B and C). While the mech-
anism by which Tor1p is recruited to the 
HMO1 gene is unclear, we note that HMO1 
promoter activity is reduced in the absence 
of Tor1p, regardless of the presence of 
Hmo1p; we therefore infer that Tor1p is un-
likely to be recruited by direct interaction 
with Hmo1p. Absence of Hmo1p results in 
significantly reduced binding of Fhl1p to the 
IFHL site (Xiao et al., 2011); however, we 
cannot rule out that residual Fhl1p binding 
may be sufficient to recruit Tor1p. It is also 
probable that the IFHL site is required not 
for Tor1p recruitment but for binding of a 
target for the TOR kinase.
During nutrient sufficiency, expression 
of HMO1 is repressed by Hmo1p, with 
overexpression of Hmo1p associated with 
further repression (Figure 1B; Xiao et al., 
2011). Because binding of the transcription 
factor Reb1p is reduced under condi-
tions of Hmo1p overexpression (Figure 
14B), we speculate that accumulation of 
excess Hmo1p on the HMO1 gene may 
displace Reb1p and therefore contribute to 
when Hmo1p is overexpressed. Consistent with the inference that 
Hmo1p-mediated repression of the HMO1 gene is independent 
of Tor1p (Figure 1B), overexpression of Hmo1p did not reduce 
association of Tor1p with the HMO1 gene (Figure 15).
FIGURE 12: Flow-cytometric analysis of cell cycle progression after induction of DSB. Total 
DNA content of asynchronous cells is presented on the x-axis and cell counts on the y-axis. WT 
(top) and tor1Δ cells (bottom) were collected before (0 min) and at the indicated times after 
addition of galactose to induce DSB. Data are representative of duplicate experiments.
FIGURE 13: Flow-cytometric analysis of cell cycle progression after addition of rapamycin. Total 
DNA content is presented on the x-axis and cell counts on the y-axis. WT (top) and tor1Δ cells 
(bottom) were collected before (0 min) and at the indicated times after addition of rapamycin. 
Data are representative of duplicate experiments.
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mRNA levels upon DSB induction correlates 
with reduced Ifh1p binding and recruitment 
of Crf1p, and the dissociation of Ifh1p is 
followed by dissociation of RNA Pol II, sug-
gesting that Ifh1p is a required activator for 
HMO1 expression (Figures 9 and 11, A and 
B). The delayed binding of Crf1p would be 
consistent with the need to import phos-
phorylated Crf1p into the nucleus. A similar 
response is also associated with rapamycin-
mediated reduction in gene expression 
(Figures 10 and 11C). Notably, the reduced 
HMO1 mRNA levels characteristic of cells 
experiencing a DSB or rapamycin treatment 
are not seen in tor1Δ cells. This suggests 
that inhibition of a cytoplasmic (vacuolar) 
mTORC1 pool in which either Tor1p or 
Tor2p may be incorporated is unlikely to be 
sufficient for the observed change in mRNA 
levels. Assuming that inhibition of cytoplas-
mic mTORC1 is required for Crf1p phos-
phorylation and its accumulation in the nucleus as previously 
proposed (Martin et al., 2004; Schawalder et al., 2004), the failure to 
elicit a decrease in mRNA levels in the absence of Tor1p is intriguing 
and may suggest a need for promoter-bound kinase in maintaining 
the phosphorylation state of key transcription factors, thus rational-
izing the binding of Tor1p to the HMO1 gene. Such transcription 
factors could include Sfp1p; Sfp1p is mainly localized in the nucleus 
during balanced growth, and it interacts directly with mTORC1, 
which was interpreted to suggest the existence of a nuclear pool of 
mTORC1 (Lempiäinen et al., 2009).
Repression of RP gene expression leads to dissociation of 
Hmo1p, while Fhl1p remains bound, an event that results in a move-
ment of the +1 nucleosome, suggesting that Hmo1p is important 
for correct assembly of the preinitiation 
complex (Reja et al., 2015). Similarly, the dis-
sociation of both Hmo1p and Tor1p from 
the HMO1 gene correlated with the lowest 
level of HMO1 expression (Figures 2, 6, and 
7). These observations reveal a previously 
unappreciated function of TOR kinase in di-
rect control of transcription by RNA Pol II, 
and they raise the possibility that control of 




All yeast strains were derived from WT strain 
DDY3, which is isogenic to W303-1a (MAT a 
ADE2 his3-11 leu2-3,112 lys2Δ trp1-1 ura3-1 
can1-100; Simms et al., 2008). The strain de-
leted for HMO1 (hmo1Δ) and strains express-
ing FLAG-tagged Hmo1p or Fhl1p were de-
scribed previously (Xiao et al., 2011). Strains 
expressing FLAG-tagged Ifh1p, Crf1p, and 
Tor1p were created by amplification of the 
sequence encoding the 3×FLAG-tag and the 
KanMX6 marker using primers carrying 
homology to the target genes. PCR products 
were used for transformation of DDY3 (or 
hmo1Δ in case of Ifh1-FLAG), followed by 
decreased gene activity, perhaps by forcing a repressive localiza-
tion of the +1 nucleosome. This negative-feedback loop may en-
sure that cellular levels of Hmo1p remain optimal; because Hmo1p 
stabilizes chromatin, excess Hmo1p may result in slower rates of 
chromatin remodeling and, therefore, compromised cellular func-
tion. That Reb1p dissociates after prolonged DSB induction when 
HMO1 expression levels are very low is consistent with its role as 
an activator (Figure 14A).
Tor1p is required for decreased HMO1 expression during 
stress
Both DSB induction and treatment with rapamycin results in re-
duced HMO1 mRNA levels (Figures 2 and 4). The initial reduction in 
FIGURE 14: Correlation between Reb1p and Hmo1p occupancy. (A) Quantification by qRT-PCR 
of ChIP using antibody to FLAG-tagged Reb1p before (Ctrl, dark blue bar) and after induction of 
DSB by addition of galactose (gray bars). DNA repair was induced by addition of glucose (blue 
hatched bars). Data were normalized to corresponding input control for each time point. Primer 
pair amplifying region containing Reb1p sites (Up1) was used. (B) Quantification by qRT-PCR of 
ChIP using antibody to FLAG-tagged Reb1p before (dark blue bar) and after induction of HMO1 
expression (light blue bars); HMO1 was under control of the strong GAL1 promoter. Data were 
normalized to corresponding input control for each time point. Primer pair–amplifying region 
containing Reb1p sites (Up1) was used.
FIGURE 15: Overexpression of Hmo1p does not result in displacement of Tor1p. Quantification 
by qRT-PCR of ChIP using antibody to FLAG-tagged Tor1p before (solid bars) and after 
induction of HMO1 expression (striped bars); HMO1 was under control of the strong GAL1 
promoter. Data were normalized to corresponding input control for each time point. Three 
independent experiments were performed. Error bars represent SD.
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verified by PCR. RNA was quantified using NanoDrop (Thermo Sci-
entific). The cDNA was prepared from 500 ng total RNA using 1X 
AMV reverse transcriptase buffer with 1 mM MgCl2, 1 mM dNTP, 
and 10 U of AMV reverse transcriptase (New England BioLabs) in a 
total reaction volume of 25 μl. The mixture was incubated at 42°C 
for 1 h. A ViiA 7 (Applied Biosystems) was used for quantitative PCR 
(qPCR) using Taq polymerase for amplification and SYBR Green I 
(Sigma) for detection. For analysis of expression after DSB induction 
or rapamycin addition, the data were normalized to the expression 
level in untreated control; expression of IPP1 (inorganic pyrophos-
phatase) was used as a reference, and relative expression in WT and 
tor1Δ cells was calculated using the ΔCt method. Each experiment 
was repeated three times, and average and SD are reported.
ChIP and PCR analysis
Yeast cells were grown at 30°C in 2% raffinose-containing yeast, 
peptone (YP) or in synthetic defined (SD) drop-out media to OD600 
∼1.0. A 100 ml culture aliquot was saved as the uninduced sample. 
Where indicated, galactose was added to the remaining culture to 
a final concentration of 2% to induce expression of HO endonucle-
ase, or rapamycin was added at a final concentration of 200 ng/ml 
to inhibit mTORC1, and cells were collected at the indicated 
times. For repressing HO expression and prevent further DNA 
damage, 2% glucose was added and cells were harvested at indi-
cated times for ChIP assay. Cells were fixed with 1.2% formalde-
hyde and incubated at room temperature for 20 min with gentle 
shaking. Cells were lysed by vortexing with glass beads for 40 min 
at 4°C in lysis buffer (50 mM HEPES, pH 7.5, 140 mM NaCl, 1% 
Triton X-100, and 0.1% sodium deoxycholate) containing protease 
inhibitors pepstatin A (1 μg/ml), leupeptin (1 μg/ml), and phenyl-
methylsulfonyl fluoride (PMSF; 100 μM). For shearing chromatin 
into fragments of a predominant size of ∼500 base pairs, the lysate 
was sonicated six times for 10 s each at 25% amplitude with inter-
mittent chilling of the samples on ice. Sheared chromatin was then 
divided into 100 μl aliquots for ChIP. The lysate was precleared 
using protein G–Sepharose beads (GE Healthcare) to reduce non-
specific binding to the beads. For immunoprecipitation, 5 μl of 
anti-FLAG antibody (F1804; Sigma) or anti-RNA Pol II CTD (05-952; 
EMD Millipore) was used. PCR products were analyzed on 1.4% 
agarose gels and stained with ethidium bromide. Quantitative re-
verse transcriptase PCR (qRT-PCR) was conducted using an ABI 
ViiA 7 sequence-detection system and SYBR Green for detection. 
Four primer pairs amplifying different regions of the HMO1 gene 
were used (Figure 1A), and primer pairs amplifying segments of 
control loci 18S rDNA, MAT, POL5, KRE5, and IPP1 (Panday et al., 
2015; Panday and Grove, 2016) were included where indicated. 
Data were normalized to corresponding input control at each time 
point. Each experiment was repeated three times, and average 
and SD are reported.
Efficiency of DSB induction
For determining the efficiency of DSB induction, qPCR was per-
formed with primer pairs flanking the break site. Cells were grown at 
30°C to an optical density at 600 nm of 1.0. An aliquot of cells was 
removed and used as no-damage control. Galactose was added to 
the remaining culture to a final concentration of 2% to induce DSB, 
and cells were collected after 1, 2, 3, and 4 h. Genomic DNA was 
isolated and used as template for PCR amplification. qPCR was con-
ducted using an ABI ViiA 7 Real Time PCR system and SYBR Green 
for detection. Experiments were repeated three times, and data are 
reported as mean with SD. Primer sequences were previously re-
ported (Panday et al., 2015).
selection for resistance to G418. Transformants were confirmed by 
PCR, and expression of tagged proteins was verified by Western blot-
ting using antibody to the FLAG-tag (F1804; Sigma). Strains tor1Δ 
and hmo1Δtor1Δ were created by amplification of the TRP1 marker 
from plasmid pRS424 (Sikorski and Hieter, 1989), and the PCR prod-
uct was used to transform DDY3 and hmo1Δ cells, followed by selec-
tion for tryptophan prototrophy and verification of transformants by 
PCR and sequencing.
Plasmids pGWt carrying the wild-type HMO1 gene under control 
of the GAL1 promoter, pHlacZ in which lacZ is expressed under con-
trol of the HMO1 promoter, and pHlacZm in which lacZ is expressed 
under control of the HMO1 promoter lacking the IFHL site were 
previously described (Xiao et al., 2011). Plasmid expressing HO en-
donuclease was a gift from J. Haber (Brandeis University) and plas-
mid expressing FLAG-tagged Reb1p was a gift from D. Donze 
(Louisiana State University; Wang and Donze, 2016).
High-efficiency transformation
Cells were grown in yeast extract, peptone, dextrose (YPD) at 30°C 
to OD600 ∼0.8, and the pelleted cells were washed with 1X phos-
phate-buffered saline (PBS); resuspended in 1X Tris, EDTA, and 
lithium acetate buffer (TEL); and left on a nutator overnight at room 
temperature. Cells were pelleted and resuspended in 100 μl 1X TEL 
per 10 ml culture and incubated at room temperature for 30 min. 
One hundred microliters of competent cells, 10 μl of carrier DNA, 
and 1 μg of plasmid DNA were mixed and incubated for 30 min. 
Seven hundred microliters of 40% polyethylene glycol (PEG) in 1X 
TEL were added to each tube and incubated at room temperature 
for 60 min without shaking. Eighty-eight microliters of dimethyl sulf-
oxide (DMSO) was added to each tube, and the cells were sub-
jected to heat shock at 42°C for 45 min. The cells were spun at 8000 
rpm for 30 s, and pellets were washed with 300 μl water and resus-
pended in 400 μl water. Two hundred microliters was plated on syn-
thetic defined (SD) drop-out media.
β-Galactosidase assay
Cells were grown overnight in selection media and used to inoculate 
a fresh culture, which was grown to mid–log phase. The OD600 was 
recorded, and the cells were harvested immediately. An aliquot 
(1.5 ml) of the culture was centrifuged, the cell pellet was washed 
with Z buffer (60 mM Na2HPO4, 40 mM NaH2PO4, 10 mM KCl, 1 mM 
MgSO4, pH 7.0), and the cells were resuspended in 300 μl of Z buf-
fer. One hundred microliters of the cell suspension was transferred 
to a fresh microcentrifuge tube, and the cells were lysed by freezing/
thawing. Z buffer (0.7 ml) containing 0.3% β-mercaptoethanol was 
placed in reaction tubes and blanks, 160 μl of freshly prepared 
4 mg/ml 2-nitrophenyl-β-galactoside (ONPG) in Z buffer was added, 
and samples were incubated at 30°C. Reactions were terminated by 
addition of 0.4 ml of 1 M Na2CO3, and the elapsed time was re-
corded. Reactions were clarified by centrifugation for 10 min at 
14,000 rpm, and A420 was measured. The β-galactosidase activity 
was calculated using the following equation: β-galactosidase (Miller) 
units = 1000 × OD420/(t × V × OD600), where t is elapsed time and 
V is assayed culture volume (0.5 ml).
RNA isolation and in vivo gene expression
Cells were grown at 30°C to OD600 ∼0.8. One milliliter of culture was 
removed to extract RNA. Cells were mixed with ice-cold diethyl py-
rocarbonate (DEPC)-treated water and centrifuged, and the pellet 
was frozen at −80°C. Total RNA was isolated using the illustra 
RNAspin Mini Isolation kit (GE Healthcare). Contaminating DNA was 
removed using Turbo DNase (Ambion), and absence of DNA was 
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Western blot
Cells were grown at 30°C to OD600 ∼0.8. Cells from 50 ml culture 
were lysed by vortexing with glass beads using lysis buffer (100 mM 
Tris-HCl, pH 8.0, 300 mM NaCl, 2 mM EDTA, 10% glycerol, 5% Tri-
ton X-100) containing 100 mM β-mercaptoethanol, 0.2 mM PMSF, 
and protease inhibitor cocktail tablet (Roche). Protein concentration 
was measured using the BCA Protein Assay Kit. Fifteen micrograms 
of protein was resolved on 12% SDS–PAGE, and the resolved pro-
teins were transferred to a polyvinylidene fluoride membrane. Anti-
FLAG (F1804; Sigma) antibody was added at a 1:1000 dilution, and 
secondary antibody was added at a dilution of 1:5000. As loading 
controls, anti-GAPDH (ab9485; Abcam) or anti–β-actin (ab184220) 
was added at 1:5000 dilution. The blots were developed using the 
CN/DAB substrate kit (ThermoFisher).
Flow-cytometric analysis of cell cycle progression
For determining the impact of rapamycin on the cell cycle, WT and 
tor1Δ cells were grown in YPD media to OD600 ∼0.8 cells, at which 
time rapamycin was added (200 ng/ml). Cells were collected at 
0 min (before addition), 10 min, 30 min, 1 h, and 2 h. For assessment 
of the impact of DSB induction on the cell cycle, WT and tor1Δ cells, 
both transformed with plasmid expressing HO endonuclease, were 
grown in 2% raffinose-containing SD dropout media (−Ura) to OD600 
∼0.6, at which time galactose was added (2%) to induce DSB. After 
induction, cells were collected at 0 min (before induction), 10 min, 
30 min, 1 h, and 2 h.
Cell pellets (107 cells) were washed with water and centrifuged. 
For fixing, 3.5 ml of 100% ethanol was added with vortexing to 
avoid aggregation, and cells were kept at room temperature for 1 h. 
The fixed cells were centrifuged and washed with 3.5 ml sodium 
citrate buffer. Cells were centrifuged and pellets were resuspended 
in 0.5 ml RNase solution (2 mg/ml RNase A in 50 mM Tris, pH 8.0, 
and 15 mM NaCl). Resuspended cells were kept at 50°C for 2 h. 
After addition of 20 μl proteinase K (20 mg/ml), cells were incubated 
for 1 h at 50°C. A 20 μl aliquot of SYBR-Green I (1 X SYBR-Green I in 
50 mM Tris, pH 7.4) was added, and cells were incubated overnight 
at 4°C. After sonication (6 s, 10% power), samples were acquired on 
a FACScan flow cytometer (BD Biosciences, San Jose, CA) config-
ured for SYBR1 fluorescence measurements. Forward and side-
scatter measurements and fluorescence measurements for DNA 
replication were made using linear amplification. A total of 30,000 
cells per sample were analyzed using Cellquest graphics software 
(BD Biosciences). A dot plot of SYBR1 width versus SYBR1 surface 
area was analyzed for the removal of aggregates by gating. Single 
cell–derived histograms were used to examine DNA cell cycle com-
ponents, G1 and G2.
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